Karin Jooss

Track

Insider profile

Currently holds positions in Gritstone Oncology Inc and Fate Therapeutics Inc

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Research, Chief Scientific Officer Gritstone Oncology Inc April 1, 2016 -
Independent Director Fate Therapeutics Inc March 18, 2019 -
Karin Jooss's trades of Gritstone Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-17 2024-05-16
S Sale
91,526 +34.3%
166.82
US$4,923,054 		91,526 +34.3% 166.82 US$4,923,054
2022-06-06 2022-06-03
S Sale
81,573 -19.0%
299.32
US$351,274 		81,573 -19.0% 299.32 US$351,274